How was Immunogenomics 2018?
We value your feedback! Did you attend the sixth annual Immunogenomics conference? Let us know what you thought about the conference and take a quick survey. The survey will close October 22.
Leading genomics and immunology researchers share expertise at Immunogenomics conference
Leading scientists traveled from all over the world to share new discoveries and advances in the fields of genomics and immunology at the sixth-annual Immunogenomics Conference (IGC) hosted by the HudsonAlpha Institute for Biotechnology. Researchers presented data on topics ranging from results of promising cancer treatment trials to the relationship between immune system cells and genetic expression.
HudsonAlpha conference to bring top researchers to the Rocket City
Leading immunology and genomics researchers from around the globe will convene at the HudsonAlpha Institute for Biotechnology in Huntsville, Ala., October 1-3 for the 6th annual Immunogenomics conference. In its sixth year, the Immunogenomics conference is truly international, attracting science leaders, faculty and students from a dozen countries.
Immunogenomics 2017 brings interdisciplinary discussions to HudsonAlpha
HudsonAlpha Institute for Biotechnology’s fifth annual Immunogenomics conference was held Oct. 2-4, 2017, on the biotech campus in Huntsville, Ala. More than 150 scientists and industry sponsors from 14 states and 12 countries around the world met to discuss this interdisciplinary area of study that applies genomic technologies to understanding the immune system and disease development. .
How was Immunogenomics 2017?
We value your feedback! Did you attend the fifth annual Immunogenomics conference? Let us know what you thought about the conference and take a quick survey. The survey will close October 23.
Immunogenomics bringing leading researchers from around the world to the Rocket City
Leading researchers from around the world will convene at HudsonAlpha Institute for Biotechnology on Oct. 2-4, 2017 for the fifth annual Immunogenomics conference. The conference provides attendees the opportunity to engage in science discussions, network with experts and discover what’s next in the field of immunogenomics and how it will help shape the future of human health.
iCubate® Earns FDA Clearance
iCubate®, Inc., an innovative molecular diagnostic device company, announced today that it has earned U.S. Food and Drug Administration (FDA) clearance for its iCubate platform, the iC-System™, and its first clinical assay, the iC-GPC Assay™, used for the rapid detection of pathogenic bacteria associated with bloodstream infection (BSI).
How a few drops of blood led to a breakthrough in immunology
Scientists from the Research Institute of the McGill University Health Centre (RI-MUHC) may have cracked the code to understanding the function of special cells called regulatory T Cells.
Alabama Department of Commerce features HudsonAlpha, IGC 2016
Faculty Investigator Jian Han, MD, PhD spoke with them about this year’s Immunogenomics conference, which brought in more than 150 researchers from around the world.
Immunogenomics 2016 a great success
According to 91% of attendees, Immunogenomics 2016 was a great success!
Test to diagnose normal health could help refocus medical system on prevention
Jian Han, MD, PhD, envisions a future when medical check-ups will include a test to determine your health index – a measure of your immune system’s readiness to ward off invading viruses. Han described his ideas at the HudsonAlpha Institute for Biotechnology’s 2015 Immunogenomics conference, held in late September in Huntsville, Ala.
Immunogenomics is the hot scientific field of the moment says Nobel laureate
More than 150 scientists from 13 countries participated in the HudsonAlpha Institute for Biotechnology’s 3rd annual Immunogenomics conference held Sept. 28 to 30, 2015, on the 152-acre campus in Huntsville, Ala.
Systems biology and infectious disease at Immunogenomics 2016
The immune system, says Alan Aderem, PhD, is both the sum of its microscopic parts and an independent entity that operates as one unit. Immunogenomics, he says, provides the details that make those two views possible.